B-和T-淋巴细胞减弱剂的泛癌风景:对潜在的免疫疗法组合的影响
Daisuke Nishizaki1, Sharon Choi1, Chinmayi Pandya1
1Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla, CA.
JCO precision oncology
|August 6, 2025
概括
在接受免疫检查点抑制剂 (ICI) 的患者中,高B和T淋巴细胞减弱剂 (BTLA) 表达与更好的生存相关. 这表明BTLA可能是新型免疫疗法组合的有价值目标.
科学领域:
- 免疫学和癌症研究
- 分子瘤学分子瘤学
- 翻译医学是一种翻译医学.
背景情况:
- 免疫检查点抑制剂 (ICI) 已经彻底改变了癌症治疗.
- 识别可共同向的新型免疫路径对于提高ICI疗效和克服耐药性至关重要.
- B-和T-淋巴细胞减弱剂 (BTLA) 是一个有前途的免疫点,在免疫调节中具有潜在的作用.
研究的目的:
- 研究BTLA在晚期/转移性实体瘤中的转录基因表达.
- 评估BTLA表达的临床影响,包括其与其他免疫检查点和患者存活率的关联.
- 探索BTLA作为新型免疫疗法策略的目标的潜力.
主要方法:
- 在514个晚期/转移性固体瘤样本上进行了RNA测序.
- 分析了BTLA,BTLA相关标记物 (HVEM,CD160,LIGHT) 和关键免疫检查点 (PD-1,PD-L1,PD-L2,CTLA-4,LAG-3) 的转录体表达.
- 使用统计分析,包括卡普兰-梅尔生存率和考克斯回归来评估与临床结果的相关性.
主要成果:
- 在19%的瘤中发现高BTLARNA表达 (≥75百分位数).
- 高BTLA表达与PD-1,CTLA-4,HVEM和CD160RNA水平升高以及乳腺癌诊断有关.
- 在ICI接受者中,高BTLA表达与单变量分析中的显著更长的存活率相关 (多变量分析中的趋势).
结论:
- 高BTLA转录表达与高水平的PD-1,CTLA-4及其配体HVEM有关.
- 这些发现支持将抗PD-1或抗CTLA-4疗法与抗BTLA药物结合的可能性.
- 个性化免疫学分析对于精确免疫疗法至关重要,因为BTLA和相关标记物在癌症中的可变表达和协同表达模式.
相关概念视频
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K